scispace - formally typeset
K

Kim A. Eagle

Researcher at University of Michigan

Publications -  852
Citations -  85694

Kim A. Eagle is an academic researcher from University of Michigan. The author has contributed to research in topics: Aortic dissection & Myocardial infarction. The author has an hindex of 129, co-authored 823 publications receiving 75160 citations. Previous affiliations of Kim A. Eagle include University of Wisconsin Hospital and Clinics & Spaulding Rehabilitation Hospital.

Papers
More filters
Journal ArticleDOI

Acute limb ischemia associated with type B aortic dissection: clinical relevance and therapy.

TL;DR: ALI secondary to AoD is predictive of death and visceral ischemia, and endovascular therapy confers excellent limb salvage and allows diagnosis of unsuspected visceral isChemia.
Journal ArticleDOI

Acute aortic dissection presenting with primarily abdominal pain: A rare manifestation of a deadly disease

TL;DR: Increased mortality in patients with acute thoracic aortic dissections who present primarily with abdominal pain is documented, underscoring the importance of maintaining a high index of suspicion for an aorta dissection in patients who have appropriate risk factors.
Journal ArticleDOI

Comparison of patients with acute coronary syndrome with and without systemic hypertension.

TL;DR: The role of systemic hypertension in acute coronary syndrome (ACS) has not been well studied, and at 6-month follow-up, age- and gender-adjusted odds ratios for adverse events were equivalent in hypertensives and normotensives, suggesting no continuing differential treatment benefit in the months after the initial ACS episode.
Journal ArticleDOI

Importance of Refractory Pain and Hypertension in Acute Type B Aortic Dissection: Insights From the International Registry of Acute Aortic Dissection (IRAD)

TL;DR: Recurrent pain and refractory hypertension appeared as clinical signs associated with increased in-hospital mortality, particularly when managed medically, and suggest that aortic intervention, such as via an endovascular approach, may be indicated in this intermediate-risk group.